RSV MEDI deltaM2-2

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRSV MEDI deltaM2-2
Drug Alias NameM2-2 RSV vaccineRSV vaccine intranasalRespiratory-syncytial virus vaccine M2-2RSV MEDI deltaM2-2 vaccineMedi-RSV-delta-M2-2 vaccine +[6] 
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedimmune LlcNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A